NM_007294.4:c.*1287C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007294.4(BRCA1):​c.*1287C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.339 in 504,982 control chromosomes in the GnomAD database, including 30,788 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.31 ( 7721 hom., cov: 32)
Exomes 𝑓: 0.35 ( 23067 hom. )

Consequence

BRCA1
NM_007294.4 3_prime_UTR

Scores

2

Clinical Significance

Benign reviewed by expert panel P:1B:6

Conservation

PhyloP100: 0.953

Publications

49 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 17-43044391-G-A is Benign according to our data. Variant chr17-43044391-G-A is described in ClinVar as Benign. ClinVar VariationId is 132777.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_007294.4
MANE Select
c.*1287C>T
3_prime_UTR
Exon 23 of 23NP_009225.1P38398-1
BRCA1
NM_001407581.1
c.*1287C>T
3_prime_UTR
Exon 24 of 24NP_001394510.1A0A2R8Y7V5
BRCA1
NM_001407582.1
c.*1287C>T
3_prime_UTR
Exon 24 of 24NP_001394511.1A0A2R8Y7V5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.*1287C>T
3_prime_UTR
Exon 23 of 23ENSP00000350283.3P38398-1
BRCA1
ENST00000471181.7
TSL:1
c.*1287C>T
3_prime_UTR
Exon 24 of 24ENSP00000418960.2P38398-7
BRCA1
ENST00000470026.6
TSL:1
c.*1287C>T
3_prime_UTR
Exon 23 of 23ENSP00000419274.2P38398-1

Frequencies

GnomAD3 genomes
AF:
0.311
AC:
47216
AN:
151928
Hom.:
7718
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.232
Gnomad AMI
AF:
0.285
Gnomad AMR
AF:
0.272
Gnomad ASJ
AF:
0.358
Gnomad EAS
AF:
0.373
Gnomad SAS
AF:
0.494
Gnomad FIN
AF:
0.405
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.332
Gnomad OTH
AF:
0.326
GnomAD2 exomes
AF:
0.342
AC:
46670
AN:
136324
AF XY:
0.357
show subpopulations
Gnomad AFR exome
AF:
0.235
Gnomad AMR exome
AF:
0.217
Gnomad ASJ exome
AF:
0.373
Gnomad EAS exome
AF:
0.382
Gnomad FIN exome
AF:
0.386
Gnomad NFE exome
AF:
0.330
Gnomad OTH exome
AF:
0.333
GnomAD4 exome
AF:
0.351
AC:
123858
AN:
352934
Hom.:
23067
Cov.:
0
AF XY:
0.366
AC XY:
71686
AN XY:
195766
show subpopulations
African (AFR)
AF:
0.234
AC:
2529
AN:
10786
American (AMR)
AF:
0.220
AC:
6304
AN:
28712
Ashkenazi Jewish (ASJ)
AF:
0.370
AC:
5168
AN:
13984
East Asian (EAS)
AF:
0.359
AC:
6225
AN:
17340
South Asian (SAS)
AF:
0.498
AC:
29918
AN:
60056
European-Finnish (FIN)
AF:
0.389
AC:
4968
AN:
12786
Middle Eastern (MID)
AF:
0.378
AC:
546
AN:
1444
European-Non Finnish (NFE)
AF:
0.328
AC:
62130
AN:
189600
Other (OTH)
AF:
0.333
AC:
6070
AN:
18226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
5009
10018
15028
20037
25046
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.311
AC:
47237
AN:
152048
Hom.:
7721
Cov.:
32
AF XY:
0.316
AC XY:
23512
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.232
AC:
9640
AN:
41486
American (AMR)
AF:
0.272
AC:
4142
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.358
AC:
1241
AN:
3466
East Asian (EAS)
AF:
0.373
AC:
1927
AN:
5172
South Asian (SAS)
AF:
0.493
AC:
2378
AN:
4826
European-Finnish (FIN)
AF:
0.405
AC:
4283
AN:
10568
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.332
AC:
22565
AN:
67964
Other (OTH)
AF:
0.331
AC:
697
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1658
3316
4975
6633
8291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.309
Hom.:
13957
Bravo
AF:
0.292
Asia WGS
AF:
0.408
AC:
1416
AN:
3470

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Breast-ovarian cancer, familial, susceptibility to, 1 (3)
-
-
2
not provided (3)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.5
DANN
Benign
0.57
PhyloP100
0.95
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12516; hg19: chr17-41196408; COSMIC: COSV58790086; COSMIC: COSV58790086; API